Immunotherapy-Associated Renal Dysfunction in Metastatic Cancer: An Emerging Challenge in Onco-Nephrology

Francesco Trevisani1, Andrea Angioi2, Michele Ghidini3

  • 1URI-Urological Research Institute, Department of Urology, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132 Milan, Italy.

Cancers
|July 12, 2025
PubMed
Abstract

Insights

Acute kidney disease (AKD) is a common complication in patients receiving immune checkpoint inhibitors (ICIs). Early identification of high-risk patients is crucial for managing kidney health during cancer immunotherapy.

Area of Science:

  • Nephrology
  • Oncology
  • Immunology

Background:

  • Immune checkpoint inhibitors (ICIs) are vital in metastatic cancer treatment but pose nephrotoxic risks.
  • Acute kidney injury (AKI) is recognized, but the subacute phase, acute kidney disease (AKD), is understudied in ICI therapy.

Purpose of the Study:

  • To investigate the incidence and predictors of acute kidney disease (AKD) in patients undergoing immune checkpoint inhibitor (ICI) therapy.
  • To characterize the clinical course and risk factors associated with AKD in this patient population.

Main Methods:

  • Retrospective cohort study of 226 adult patients receiving ICIs.
  • AKD diagnosis based on 2024 Kidney Disease: Improving Global Outcomes (KDIGO) criteria.
  • Multivariable logistic regression identified AKD predictors.

Main Results:

  • AKD occurred in 20.4% of patients within 90 days of ICI initiation.
  • Higher body surface area and baseline NSAID use were independent AKD predictors (OR 8.17, OR 29.74).
  • A predictive model demonstrated good discrimination (AUC 0.778).

Conclusions:

  • Acute kidney disease (AKD) is a frequent, underrecognized complication of ICIs.
  • Identifying high-risk patients and implementing renal monitoring can improve safety and treatment.
  • AKD has implications for both renal function and cancer treatment outcomes.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
83
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
58
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
164
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
31
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
77